Menu

Blog

Jan 18, 2018

Why Gene Silencing Could Launch a New Class of Blockbuster Drugs

Posted by in category: biotech/medical

Over 85 percent of proteins in the body can’t be targeted with conventional chemical drugs. By working on the RNA responsible for problematic proteins, gene silencing opens up an enormous portion of the genome to intervention. If realized, a new class of drugs based on gene silencing could overhaul modern medicine.

Read more

Comments are closed.